ReviewPharmaceutics2021

Patient-Derived Induced Pluripotent Stem Cells (iPSCs) and Cerebral Organoids for Drug Screening and Development in Autism Spectrum Disorder: Opportunities and Challenges.

Chiara Villa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.